tldrdaily.news logo

Otsuka's Kidney Disease Drug Achieves Over 50% Reduction in Urinary Protein Levels

1 min read
Source: statnews.com
Otsuka's Kidney Disease Drug Achieves Over 50% Reduction in Urinary Protein Levels
Photo: statnews.com
TL;DR Summary

Otsuka's experimental drug sibeprenlimab showed promising results in reducing toxic protein levels in patients with IgA nephropathy, outperforming Vera Therapeutics in a Phase 3 study, with fewer serious side effects.

Topics:business#clinical-trial#health#iga-nephropathy#kidney-disease#otsuka#vera-therapeutics
Share this article
  1. Otsuka tops Vera Therapeutics in kidney disease study showdown  statnews.com
  2. Otsuka's kidney disease drug cuts protein levels in urine by more than half  marketscreener.com
  3. ERA 2025: Sibeprenlimab Halves Proteinuria in IgAN in Phase 3 VISIONARY Trial  HCPLive
  4. Otsuka's kidney disease drug shows over 50% reduction in protein in urine  TradingView

Reading Insights

Total Reads

0

Unique Readers

0

Time Saved

1 min

vs 2 min read

Condensed

89%

270 → 30 words

Want the full story? Read the original article

Read on statnews.com